Vimarsana
Biggest News Aggregation in the World

Donna Messner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Donna Messner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Donna Messner Today - Breaking & Trending Today

Green Park Collaborative and Allergy & Asthma Network Publish a Core Outcome Set for Clinical Trials in Moderate to Severe Asthma - Vimarsana News

Green Park Collaborative and Allergy & Asthma Network Publish a Core Outcome Set for Clinical Trials in Moderate to Severe Asthma

Green Park Collaborative and Allergy & Asthma Network Publish a Core Outcome Set for Clinical Trials in Moderate to Severe Asthma News provided by Share this article Share this article core across all phase 3 and 4 clinical drug trials for moderate to severe asthma. The report, published in the Annals of Allergy, Asthma and Immunology, describes the multi-stakeholder consensus process used to prioritize nearly 100 outcomes down to a final set of five core outcomes. Participants represented many perspectives, including patients, clinicians, researchers, payers, health technology assessors, reg...

Green Park Collaborative and COPD Foundation Launch coreCOPD to Develop Consensus on Critical Outcomes for Stable COPD - Vimarsana News

Green Park Collaborative and COPD Foundation Launch coreCOPD to Develop Consensus on Critical Outcomes for Stable COPD

Green Park Collaborative and COPD Foundation Launch coreCOPD to Develop Consensus on Critical Outcomes for Stable COPD News provided by Share this article Share this article BALTIMORE, Dec. 23, 2020 /PRNewswire/ -- The Green Park Collaborative (GPC), a major initiative of the Center for Medical Technology Policy (CMTP), is partnering with The COPD Foundation to develop a core set of outcomes to be used in late phase clinical trials of therapies for stable chronic obstructive pulmonary disease (COPD). This initiative, coreCOPD, will engage patients, clinicians, researchers, regulators, payers,...